A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer resistance to enzalutamide, a frequently used drug. The article is published in ...

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...

Prostate cancer hijacks the normal prostate's growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers. The discovery, published Dec. 13 in ...

The FDA Just Approved a New Drug for an Aggressive Form of Prostate Cancer — and It Targets the Disease in a Way No Approved Drug Has Before ...

Researchers have developed a fully human antibody that suppressed tumor growth and metastatic spread in preclinical models of ...

According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime. In addition, about 1 in 44 men will die from the disease, ...

Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...

Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate cancer cells—an important process that may help explain how some tumors progress ...

Prostate cancer is one of the most common malignant tumors in men, ranking second in global male cancer incidence and first in Europe and North America. Although therapies targeting androgen and the ...

Weight management medication utilization and outpatient costs in patients with prostate cancer and diabetes. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium. This abstract ...